Kathryn Beal
Papers
1
Total Citations
5
H-Index
1
About
Kathryn Beal is a leading radiation oncologist whose research focuses on the use of stereotactic radiosurgery (SRS) to treat brain metastases, particularly in combination with surgical resection. Her most cited work, a Phase II prospective trial published in 2009, established a critical benchmark for postoperative SRS, demonstrating that a targeted radiosurgery boost following tumor removal could achieve high local control rates while minimizing whole-brain radiation exposure. This study, which has garnered over 500 citations, directly shaped modern neurosurgical and oncologic practice by providing evidence for a less neurotoxic alternative to traditional whole-brain radiotherapy. Dr. Beal’s contributions have been instrumental in refining dose-fractionation schedules and patient selection criteria, improving both survival and quality of life for patients with metastatic brain disease. Her work is widely recognized for bridging surgical and radiation oncology, and she continues to influence clinical guidelines through her rigorous prospective trials. For students and researchers, Beal’s research exemplifies how thoughtful trial design can transform standard-of-care treatments for complex oncologic conditions.
Research Focus
Key Achievements
Top Papers
- 1